Sara A. Hurvitz, M.D., reviews the history of HER2+ breast cancer and the progressive research that has been done in this disease.
Videos
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, describes her experience learning about the surplus of treatment options and how she overcame her initial apprehension.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her initial impression of when she was diagnosed.
Sara A. Hurvitz, M.D., describes the subtypes, staging and grading of breast cancer.
Improving Outcomes for Patients With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
A Caregiver’s Perspective on Treatment Success
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Feeling Supported During the Diagnosis and Treatment of Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
View the full CURE Educated Patient Multiple Myeloma Summit on demand.
George Valentine needs something from his elected representatives in Congress: securing predictable annual out-of-pocket costs under Medicare Part D’s prescription drug plan.
Nearly one year ago to the day, 24-year-old Nina Luker was completely blindsided by a diagnosis of non-Hodgkin lymphoma. But after powering through treatments in the thick of the COVID-19 pandemic, Luker is now cancer-free and offering advice to those who may be looking for ways to help their loved ones through difficult times of their own.
Effect of Brain Metastasis Treatment on Quality of Life
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Individual Assessment of Treatment Success With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
View the full CURE Educated Patient Breast Cancer Summit on demand.
View the full CURE Educated Patient Lung Cancer Summit on demand.
While it is important to educate oneself after receiving a diagnosis of cancer, it’s also critical to know when to step away and find a balance between cancer and life, according to Diane Zipursky-Quale.
Personal Concerns With Treatment Options for Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Importance of Clinical Trial Enrollment for Patients With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Positive results from the phase 3 CLEAR clinical trial, presented at the 2021 ASCO Genitourinary Cancers Symposium, are just one more dataset that could offer “a sense of hope and promise” for patients with advanced renal cell carcinoma (RCC), says the study’s lead author, Dr. Robert J. Motzer.
Factors Considered When Selecting Treatment for Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Systemic Therapies Used for Cancer That Has Spread to the Brain
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Breast cancer survivor and Evofem Biosciences founder and CEO Saundra Pelletier shares her thoughts on a new hormone-free contraceptive gel that could improve sexual quality of life in patients with cancer.
Watch CURE®'s EDUCATED PATIENT® Webinar: Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing.
Ahead of the release of their book, “Off Our Chests”, Dr. John Marshall and his wife, Liza, look back on the trials and tribulations of Liza’s triple-negative breast cancer diagnosis – from the perspective of a patient and her husband, the caregiver and oncologist.
Role of Radiotherapy and Radiosurgery for Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Discussing Goals of Treatment With Patients and Caregivers
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
For patients to maintain or improve their quality of life through their cancer treatment, it is pivotal that they communicate with their health care team.
Advertisement
Advertisement
Trending on CURE
1
FDA Accepts Gedatolisib Application for Some With Breast Cancer
2
FDA Grants Breakthrough Designation to Sofi-cel for Relapsed/Refractory T-Cell ALL/LBL
3
FDA Orphan Drug Designation Granted to Zavabresib for Myelofibrosis
4
CAR-NK Shows Long-Term Response in Waldenström Non-Hodgkin Lymphoma
5